| 1 |
Li C, Wang Z, Lei H, Zhang D. Recent progress in nanotechnology-based drug carriers for resveratrol delivery. Drug Deliv 2023;30:2174206. [PMID: 36852655 DOI: 10.1080/10717544.2023.2174206] [Reference Citation Analysis]
|
| 2 |
Antunes JL, Amado J, Veiga F, Paiva-Santos AC, Pires PC. Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs. Pharmaceutics 2023;15:998. [PMID: 36986859 DOI: 10.3390/pharmaceutics15030998] [Reference Citation Analysis]
|
| 3 |
Fathi-Karkan S, Mirinejad S, Ulucan-Karnak F, Mukhtar M, Almanghadim HG, Sargazi S, Rahdar A, Díez-Pascual AM. Biomedical applications of aptamer-modified chitosan nanomaterials: An updated review. Int J Biol Macromol 2023;:124103. [PMID: 36948344 DOI: 10.1016/j.ijbiomac.2023.124103] [Reference Citation Analysis]
|
| 4 |
Yang Q, Pu W, Hu K, Hu Y, Feng Z, Cai J, Li C, Li L, Zhou Z, Zhang J. Reactive Oxygen Species-Responsive Transformable and Triple-Targeting Butylphthalide Nanotherapy for Precision Treatment of Ischemic Stroke by Normalizing the Pathological Microenvironment. ACS Nano 2023;17:4813-33. [PMID: 36802489 DOI: 10.1021/acsnano.2c11363] [Reference Citation Analysis]
|
| 5 |
Cutroneo M, Torrisi L, Silipigni L, Havranek V, Mackova A, Malinsky P, Miksova R, Maly J, Stofik M, Aubrecht P, Fajstavr D, Slepicka P. Laminated Cyclic Olefin Copolymer Foil by Pulsed Laser Deposition. Coatings 2023;13:596. [DOI: 10.3390/coatings13030596] [Reference Citation Analysis]
|
| 6 |
Lee CY, Chooi WH, Ng SY, Chew SY. Modulating neuroinflammation through molecular, cellular and biomaterial-based approaches to treat spinal cord injury. Bioeng Transl Med 2023;8:e10389. [PMID: 36925680 DOI: 10.1002/btm2.10389] [Reference Citation Analysis]
|
| 7 |
Ashley J, Potts IG, Olorunniji FJ. Applications of Terminal Deoxynucleotidyl Transferase Enzyme in Biotechnology. Chembiochem 2023;24:e202200510. [PMID: 36342345 DOI: 10.1002/cbic.202200510] [Reference Citation Analysis]
|
| 8 |
Angolkar M, Paramshetti S, Halagali P, Jain V, Patil AB, Somanna P. Nanotechnological advancements in the brain tumor therapy: a novel approach. Ther Deliv 2023. [PMID: 36802944 DOI: 10.4155/tde-2022-0035] [Reference Citation Analysis]
|
| 9 |
Wu D, Lim BXH, Seah I, Xie S, Jaeger JE, Symons RK, Heffernan AL, Curren EEM, Leong SCY, Riau AK, Lim DKA, Stapleton F, Ali MJ, Singh S, Tong L, Mehta JS, Su X, Lim CHL. Impact of Microplastics on the Ocular Surface. Int J Mol Sci 2023;24. [PMID: 36835339 DOI: 10.3390/ijms24043928] [Reference Citation Analysis]
|
| 10 |
Hasan I, Roy S, Guo B, Du S, Tao W, Chang C. Recent progress in nanomedicines for imaging and therapy of brain tumors. Biomater Sci 2023;11:1270-310. [PMID: 36648496 DOI: 10.1039/d2bm01572b] [Reference Citation Analysis]
|
| 11 |
Li Q, Wen J, Yan Z, Sun H, Song E, Song Y. Mechanistic Insights of TiO(2) Nanoparticles with Different Surface Charges on Aβ(42) Peptide Early Aggregation: An In Vitro and In Silico Study. Langmuir 2023;39:1997-2007. [PMID: 36706054 DOI: 10.1021/acs.langmuir.2c03065] [Reference Citation Analysis]
|
| 12 |
Wu SY, Ye YX, Zhang Q, Kang QJ, Xu ZM, Ren SZ, Lin F, Duan YT, Xu HJ, Hu ZY, Yang SS, Zhu HL, Zou MJ, Wang ZC. Multifunctional Protein Hybrid Nanoplatform for Synergetic Photodynamic-Chemotherapy of Malignant Carcinoma by Homologous Targeting Combined with Oxygen Transport. Adv Sci (Weinh) 2023;10:e2203742. [PMID: 36541716 DOI: 10.1002/advs.202203742] [Reference Citation Analysis]
|
| 13 |
Bazi Alahri M, Jibril Ibrahim A, Barani M, Arkaban H, Shadman SM, Salarpour S, Zarrintaj P, Jaberi J, Turki Jalil A. Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform. Molecules 2023;28. [PMID: 36677899 DOI: 10.3390/molecules28020841] [Reference Citation Analysis]
|
| 14 |
Ashraf H, Cossu D, Ruberto S, Noli M, Jasemi S, Simula ER, Sechi LA. Latent Potential of Multifunctional Selenium Nanoparticles in Neurological Diseases and Altered Gut Microbiota. Materials (Basel) 2023;16. [PMID: 36676436 DOI: 10.3390/ma16020699] [Reference Citation Analysis]
|
| 15 |
Shabani L, Abbasi M, Azarnew Z, Amani AM, Vaez A. Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience. Biomed Eng Online 2023;22:1. [PMID: 36593487 DOI: 10.1186/s12938-022-01062-y] [Reference Citation Analysis]
|
| 16 |
Mazahir F, Bhogale D, Palai AK, Yadav AK. Nanomedicine: Principles, properties, and regulatory issues. Smart Polymeric Nano-Constructs in Drug Delivery 2023. [DOI: 10.1016/b978-0-323-91248-8.00014-3] [Reference Citation Analysis]
|
| 17 |
Russell P, Esser L, Hagemeyer CE, Voelcker NH. The potential impact of nanomedicine on COVID-19-induced thrombosis. Nat Nanotechnol 2023;18:11-22. [PMID: 36536042 DOI: 10.1038/s41565-022-01270-6] [Reference Citation Analysis]
|
| 18 |
Minh Tran, Chaejeong Heo, Luke P. Lee, Hansang Cho. Human mini-blood–brain barrier models for biomedical neuroscience research: a review. Biomater Res 2022;26:82. [PMID: 36527159 DOI: 10.1186/s40824-022-00332-z] [Reference Citation Analysis]
|
| 19 |
Qi H, Zhang S, Liang J, He S, Wang Y. Controllable blood–brain barrier (BBB) regulation based on gigahertz acoustic streaming. Nanotechnology and Precision Engineering 2022;5:043001. [DOI: 10.1063/10.0014861] [Reference Citation Analysis]
|
| 20 |
Siafaka PI, Okur ME, Erim PD, Çağlar EŞ, Özgenç E, Gündoğdu E, Köprülü REP, Karantas ID, Üstündağ Okur N. Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today? Pharmaceutics 2022;14:2425. [DOI: 10.3390/pharmaceutics14112425] [Reference Citation Analysis]
|
| 21 |
Bhalothia C, Nagda G. Nanotherapeutics a promising approach for treatment of Parkinson’s disease. Materials Today: Proceedings 2022. [DOI: 10.1016/j.matpr.2022.10.311] [Reference Citation Analysis]
|
| 22 |
Zhang L, Liu Y, Huang H, Xie H, Zhang B, Xia W, Guo B. Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors. Adv Drug Deliv Rev 2022;190:114536. [PMID: 36108792 DOI: 10.1016/j.addr.2022.114536] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 23 |
Liao G, Zhang L, Li C, Liu S, Fang B, Yang H. Emerging carbon-supported single-atom catalysts for biomedical applications. Matter 2022;5:3341-3374. [DOI: 10.1016/j.matt.2022.07.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Smith BC, Tinkey RA, Shaw BC, Williams JL. Targetability of the neurovascular unit in inflammatory diseases of the central nervous system. Immunol Rev 2022;311:39-49. [PMID: 35909222 DOI: 10.1111/imr.13121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 25 |
Huang S, Hao XY, Li YJ, Wu JY, Xiang DX, Luo S. Nonviral delivery systems for antisense oligonucleotide therapeutics. Biomater Res 2022;26:49. [PMID: 36180936 DOI: 10.1186/s40824-022-00292-4] [Reference Citation Analysis]
|
| 26 |
Ciciriello AJ, Surnar B, Medy GD, Su X, Dhar S, Dumont CM. Biomaterial-targeted precision nanoparticle delivery to the injured spinal cord. Acta Biomater 2022:S1742-7061(22)00560-8. [PMID: 36087868 DOI: 10.1016/j.actbio.2022.08.077] [Reference Citation Analysis]
|
| 27 |
de Barros C, Portugal I, Batain F, Portella D, Severino P, Cardoso J, Arcuri P, Chaud M, Alves T. Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems. RPS Pharmacy and Pharmacology Reports 2022;1. [DOI: 10.1093/rpsppr/rqac003] [Reference Citation Analysis]
|
| 28 |
Carton F, Malatesta M. In Vitro Models of Biological Barriers for Nanomedical Research. IJMS 2022;23:8910. [DOI: 10.3390/ijms23168910] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 29 |
Li C, Qin S, Wen Y, Zhao W, Huang Y, Liu J. Overcoming the blood-brain barrier: Exosomes as theranostic nanocarriers for precision neuroimaging. J Control Release 2022;349:902-16. [PMID: 35932883 DOI: 10.1016/j.jconrel.2022.08.002] [Reference Citation Analysis]
|
| 30 |
La Barbera L, Mauri E, D’amelio M, Gori M. Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives. Front Neurosci 2022;16:939855. [DOI: 10.3389/fnins.2022.939855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Caraway CA, Gaitsch H, Wicks EE, Kalluri A, Kunadi N, Tyler BM. Polymeric Nanoparticles in Brain Cancer Therapy: A Review of Current Approaches. Polymers 2022;14:2963. [DOI: 10.3390/polym14142963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 32 |
Luo M, Lee LKC, Peng B, Choi CHJ, Tong WY, Voelcker NH. Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases. Advanced Science. [DOI: 10.1002/advs.202201740] [Reference Citation Analysis]
|
| 33 |
Ramakrishnan S, Li H, Xu Y, Shin D, Dursun I, Cotlet M, Zhang Y, Yu Q. Ruddlesden–Popper Perovskites with Narrow Phase Distribution for Air‐Stable Solar Cells. Solar RRL. [DOI: 10.1002/solr.202200490] [Reference Citation Analysis]
|
| 34 |
Wamhoff EC, Romanov A, Huang H, Read BJ, Ginsburg E, Knappe GA, Kim HM, Farrell NP, Irvine DJ, Bathe M. Controlling Nuclease Degradation of Wireframe DNA Origami with Minor Groove Binders. ACS Nano 2022. [PMID: 35640255 DOI: 10.1021/acsnano.1c11575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 35 |
Mir M, Palma-Florez S, Lagunas A, López-Martínez MJ, Samitier J. Biosensors Integration in Blood-Brain Barrier-on-a-Chip: Emerging Platform for Monitoring Neurodegenerative Diseases. ACS Sens 2022;7:1237-47. [PMID: 35559649 DOI: 10.1021/acssensors.2c00333] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 36 |
Naki T, Aderibigbe BA. Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer. Pharmaceutics 2022;14:1048. [DOI: 10.3390/pharmaceutics14051048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Ramburrun P, Khan RA, Choonara YE. Design, preparation, and functionalization of nanobiomaterials for enhanced efficacy in current and future biomedical applications. Nanotechnology Reviews 2022;11:1802-26. [DOI: 10.1515/ntrev-2022-0106] [Reference Citation Analysis]
|
| 38 |
Liu Y, Yang G, Hui Y, Ranaweera S, Zhao CX. Microfluidic Nanoparticles for Drug Delivery. Small 2022;:e2106580. [PMID: 35396770 DOI: 10.1002/smll.202106580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 39 |
Tehrani SF, Rabanel J, Legeay S, Cayon J, Riou J, Saulnier P, Marleau S, Gaëlle Roullin V, Hildgen P, Bastiat G. Tailoring PEGylated nanoparticle surface modulates inflammatory response in vascular endothelial cells. European Journal of Pharmaceutics and Biopharmaceutics 2022. [DOI: 10.1016/j.ejpb.2022.04.003] [Reference Citation Analysis]
|
| 40 |
Bendre A, Bhat MP, Lee K, Altalhi T, Alruqi MA, Kurkuri M. Recent developments in microfluidic technology for synthesis and toxicity-efficiency studies of biomedical nanomaterials. Materials Today Advances 2022;13:100205. [DOI: 10.1016/j.mtadv.2022.100205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 41 |
Annu, Sartaj A, Qamar Z, Md S, Alhakamy NA, Baboota S, Ali J. An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor. Front Bioeng Biotechnol 2022;10:788128. [DOI: 10.3389/fbioe.2022.788128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 42 |
Wang L, Li Y, Ren M, Wang X, Li L, Liu F, Lan Y, Yang S, Song J. pH and lipase-responsive nanocarrier-mediated dual drug delivery system to treat periodontitis in diabetic rats. Bioactive Materials 2022. [DOI: 10.1016/j.bioactmat.2022.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 43 |
Wijaya A, Wang Y, Tang D, Zhong Y, Liu B, Yan M, Jiu Q, Wu W, Wang G. A study of lovastatin and L-arginine co-loaded PLGA nanomedicine for enhancing nitric oxide production and eNOS expression. J Mater Chem B 2022;10:607-24. [PMID: 34994373 DOI: 10.1039/d1tb01455b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. Drug release study of the chitosan-based nanoparticles. Heliyon 2022;8:e08674. [PMID: 35028457 DOI: 10.1016/j.heliyon.2021.e08674] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
|
| 45 |
Dighe P. Biomedical applications of nanocarriers in brain tumor targeting. Nanocarriers for Drug-Targeting Brain Tumors 2022. [DOI: 10.1016/b978-0-323-90773-6.00011-7] [Reference Citation Analysis]
|
| 46 |
Salehi Moghaddam A, Salehi Moghaddam Z, Davachi SM, Sarikhani E, Nemati Mahand S, Khonakdar HA, Bagher Z, Ashammakhi N. Recent advances and future prospects of functional organ-on-a-chip systems. Mater Chem Front 2022. [DOI: 10.1039/d2qm00072e] [Reference Citation Analysis]
|
| 47 |
Bonilla L, Esteruelas G, Ettcheto M, Espina M, García ML, Camins A, Souto EB, Cano A, Sánchez-López E. Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges. Epilepsia Open 2021. [PMID: 34862851 DOI: 10.1002/epi4.12567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 48 |
Ribovski L, Hamelmann NM, Paulusse JMJ. Polymeric Nanoparticles Properties and Brain Delivery. Pharmaceutics 2021;13:2045. [PMID: 34959326 DOI: 10.3390/pharmaceutics13122045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 49 |
Rabha B, Bharadwaj KK, Pati S, Choudhury BK, Sarkar T, Kari ZA, Edinur HA, Baishya D, Atanase LI. Development of Polymer-Based Nanoformulations for Glioblastoma Brain Cancer Therapy and Diagnosis: An Update. Polymers (Basel) 2021;13:4114. [PMID: 34883617 DOI: 10.3390/polym13234114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 50 |
Ravichandran V, Lee M, Nguyen Cao TG, Shim MS. Polysorbate-Based Drug Formulations for Brain-Targeted Drug Delivery and Anticancer Therapy. Applied Sciences 2021;11:9336. [DOI: 10.3390/app11199336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 51 |
Zheng M, Du Q, Wang X, Zhou Y, Li J, Xia X, Lu Y, Yin J, Zou Y, Park JB, Shi B. Tuning the Elasticity of Polymersomes for Brain Tumor Targeting. Adv Sci (Weinh) 2021;8:e2102001. [PMID: 34423581 DOI: 10.1002/advs.202102001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 52 |
Nair AL, Mesch L, Schulz I, Becker H, Raible J, Kiessling H, Werner S, Rothbauer U, Schmees C, Busche M, Trennheuser S, Fricker G, Stelzle M. Parallelizable Microfluidic Platform to Model and Assess In Vitro Cellular Barriers: Technology and Application to Study the Interaction of 3D Tumor Spheroids with Cellular Barriers. Biosensors (Basel) 2021;11:314. [PMID: 34562904 DOI: 10.3390/bios11090314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 53 |
Pensado-López A, Fernández-Rey J, Reimunde P, Crecente-Campo J, Sánchez L, Torres Andón F. Zebrafish Models for the Safety and Therapeutic Testing of Nanoparticles with a Focus on Macrophages. Nanomaterials (Basel) 2021;11:1784. [PMID: 34361170 DOI: 10.3390/nano11071784] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
